Our proprietary SCS injection treatment approach offers unprecedented access to the back of the eye where sight-threatening disease often occurs. Our unique platform is inherently flexible and intended to work with established medications, new formulations of medicines, as well as future innovations, that can be delivered via suprachoroidal administration.

The following videos are taken from actual patient injections and may be considered graphic to some viewers.

Learn more about our approach
Check out our pipeline